TABLE 3

Covalent binding yields of the drugs tested incubated with RLMs


Drug

Covalent Binding (Mean ± S.D.)
Complete
(-) NADP
NADPH-Dependent
pmol/mg protein
Aminopyrine* 90.2 ± 5.4 36.2 ± 20.7 54.0
Amodiaquine* 125.6 ± 11.4 94.3 ± 2.7 31.4
Benzbromarone* 313.0 ± 79.4 7.2 ± 0.9 305.9
Clozapine* 117.6 ± 4.3 60.1 ± 12.8 57.5
Erythromycin 34.9 ± 4.7 2.7 ± 0.3 32.1
Flutamide* 106.5 ± 0.1 29.5 ± 6.4 77.0
Imipramine 234.7 ± 11.2 130.6 ± 21.0 104.1
Nevirapine* 49.5 ± 1.2 16.1 ± 2.0 33.3
Phenacetin 18.4 ± 1.7 11.4 ± 2.9 7.0
Phenytoin 17.2 ± 4.7 1.7 ± 0.3 15.5
Procainamide 26.8 ± 3.8 3.5 ± 0.4 23.3
Sulfamethoxazole 7.2 ± 0.1 1.0 ± 0.0 6.2
Tacrine 18.9 ± 1.1 1.9 ± 0.1 17.0
Valproic acid* 4.3 ± 0.7 4.9 ± 1.2 -0.6
Zafirlukast 45.6 ± 4.0 2.8 ± 0.3 42.9
Zomepirac* 5.7 ± 0.4 1.8 ± 0.0 3.9
Amlodipine 7.5 ± 0.2 5.4 ± 0.8 2.1
Caffeine 7.4 ± 1.8 11.7 ± 2.2 -4.3
Valsartan 0.8 ± 0.1 0 ± 0 0.8
Warfarin
41.1 ± 7.8
5.6 ± 1.1
35.5
  • * “Withdrawn” or “black box warning” drugs.